Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Study Coverage

1.1 PCR-based Enteric Disease Testing Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Introduction

1.2 Global PCR-based Enteric Disease Testing Outlook 2017 VS 2022 VS 2028

1.2.1 Global PCR-based Enteric Disease Testing Market Size for the Year 2017-2028

1.2.2 Global PCR-based Enteric Disease Testing Market Size for the Year 2017-2028

1.3 PCR-based Enteric Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.3.1 The Market Share of United States PCR-based Enteric Disease Testing in Global, 2017 VS 2022 VS 2028

1.3.2 The Growth Rate of PCR-based Enteric Disease Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4 PCR-based Enteric Disease Testing Market Dynamics

1.4.1 PCR-based Enteric Disease Testing Industry Trends

1.4.2 PCR-based Enteric Disease Testing Market Drivers

1.4.3 PCR-based Enteric Disease Testing Market Challenges

1.4.4 PCR-based Enteric Disease Testing Market Restraints

1.5 Study Objectives

1.6 Years Considered

2 PCR-based Enteric Disease Testing by Type

2.1 PCR-based Enteric Disease Testing Market Segment by Type

2.1.1 Analyzers/Instruments

2.1.2 Kits/Panels

2.2 Global PCR-based Enteric Disease Testing Market Size by Type (2017, 2022 & 2028)

2.3 Global PCR-based Enteric Disease Testing Market Size by Type (2017-2028)

2.4 United States PCR-based Enteric Disease Testing Market Size by Type (2017, 2022 & 2028)

2.5 United States PCR-based Enteric Disease Testing Market Size by Type (2017-2028)

3 PCR-based Enteric Disease Testing by Application

3.1 PCR-based Enteric Disease Testing Market Segment by Application

3.1.1 Clostridium Difficile

3.1.2 Campylobacteriosis

3.1.3 Cholera

3.1.4 E. coli Infection

3.1.5 H. pylori Infection

3.1.6 Salmonellosis

3.1.7 Shigellosis

3.1.8 Rotavirus Infection

3.1.9 Norovirus Infection

3.1.10 Parasitic Enteric Disease

3.2 Global PCR-based Enteric Disease Testing Market Size by Application (2017, 2022 & 2028)

3.3 Global PCR-based Enteric Disease Testing Market Size by Application (2017-2028)

3.4 United States PCR-based Enteric Disease Testing Market Size by Application (2017, 2022 & 2028)

3.5 United States PCR-based Enteric Disease Testing Market Size by Application (2017-2028)

4 Global PCR-based Enteric Disease Testing Competitor Landscape by Company

4.1 Global PCR-based Enteric Disease Testing Market Size by Company

4.1.1 Top Global PCR-based Enteric Disease Testing Companies Ranked by Revenue (2021)

4.1.2 Global PCR-based Enteric Disease Testing Revenue by Player (2017-2022)

4.2 Global PCR-based Enteric Disease Testing Concentration Ratio (CR)

4.2.1 PCR-based Enteric Disease Testing Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Companies of PCR-based Enteric Disease Testing in 2021

4.2.3 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global PCR-based Enteric Disease Testing Headquarters, Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Type

4.3.1 Global PCR-based Enteric Disease Testing Headquarters and Area Served

4.3.2 Global PCR-based Enteric Disease Testing Companies Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Type

4.3.3 Date of International Companies Enter into PCR-based Enteric Disease Testing Market

4.4 Companies Mergers & Acquisitions, Expansion Plans

4.5 United States PCR-based Enteric Disease Testing Market Size by Company

4.5.1 Top PCR-based Enteric Disease Testing Players in United States, Ranked by Revenue (2021)

4.5.2 United States PCR-based Enteric Disease Testing Revenue by Players (2020, 2021 & 2022)

5 Global PCR-based Enteric Disease Testing Market Size by Region

5.1 Global PCR-based Enteric Disease Testing Market Size by Region: 2017 VS 2022 VS 2028

5.2 Global PCR-based Enteric Disease Testing Market Size by Region (2017-2028)

5.2.1 Global PCR-based Enteric Disease Testing Market Size by Region: 2017-2022

5.2.2 Global PCR-based Enteric Disease Testing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

6.1 North America

6.1.1 North America PCR-based Enteric Disease Testing Market Size YoY Growth 2017-2028

6.1.2 North America PCR-based Enteric Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 U.S.

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.2.12 Philippines

6.3 Europe

6.3.1 Europe PCR-based Enteric Disease Testing Market Size YoY Growth 2017-2028

6.3.2 Europe PCR-based Enteric Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America PCR-based Enteric Disease Testing Market Size YoY Growth 2017-2028

6.4.2 Latin America PCR-based Enteric Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa PCR-based Enteric Disease Testing Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa PCR-based Enteric Disease Testing Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Company Details

7.1.2 Thermo Fisher Scientific Business Overview

7.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction

7.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.1.5 Thermo Fisher Scientific Recent Development

7.2 Vela Diagnostics

7.2.1 Vela Diagnostics Company Details

7.2.2 Vela Diagnostics Business Overview

7.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction

7.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.2.5 Vela Diagnostics Recent Development

7.3 CorisBioconcept

7.3.1 CorisBioconcept Company Details

7.3.2 CorisBioconcept Business Overview

7.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction

7.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.3.5 CorisBioconcept Recent Development

7.4 Meridian Life Science

7.4.1 Meridian Life Science Company Details

7.4.2 Meridian Life Science Business Overview

7.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction

7.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.4.5 Meridian Life Science Recent Development

7.5 Bio-Rad Laboratories

7.5.1 Bio-Rad Laboratories Company Details

7.5.2 Bio-Rad Laboratories Business Overview

7.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction

7.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.5.5 Bio-Rad Laboratories Recent Development

7.6 Abbott (ALERE)

7.6.1 Abbott (ALERE) Company Details

7.6.2 Abbott (ALERE) Business Overview

7.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction

7.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.6.5 Abbott (ALERE) Recent Development

7.7 bioMerieux SA

7.7.1 bioMerieux SA Company Details

7.7.2 bioMerieux SA Business Overview

7.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction

7.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.7.5 bioMerieux SA Recent Development

7.8 Trinity Biotech

7.8.1 Trinity Biotech Company Details

7.8.2 Trinity Biotech Business Overview

7.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction

7.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.8.5 Trinity Biotech Recent Development

7.9 DiaSorin Molecular

7.9.1 DiaSorin Molecular Company Details

7.9.2 DiaSorin Molecular Business Overview

7.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction

7.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.9.5 DiaSorin Molecular Recent Development

7.10 Etta Healthcare (Ovagene Oncology)

7.10.1 Etta Healthcare (Ovagene Oncology) Company Details

7.10.2 Etta Healthcare (Ovagene Oncology) Business Overview

7.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction

7.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.10.5 Etta Healthcare (Ovagene Oncology) Recent Development

7.11 ExcitePCR (PositiveID Corporation)

7.11.1 ExcitePCR (PositiveID Corporation) Company Details

7.11.2 ExcitePCR (PositiveID Corporation) Business Overview

7.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction

7.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.11.5 ExcitePCR (PositiveID Corporation) Recent Development

7.12 Flow Alliance

7.12.1 Flow Alliance Company Details

7.12.2 Flow Alliance Business Overview

7.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction

7.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.12.5 Flow Alliance Recent Development

7.13 Fluid-Screen

7.13.1 Fluid-Screen Company Details

7.13.2 Fluid-Screen Business Overview

7.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction

7.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.13.5 Fluid-Screen Recent Development

7.14 FluimediX

7.14.1 FluimediX Company Details

7.14.2 FluimediX Business Overview

7.14.3 FluimediX PCR-based Enteric Disease Testing Introduction

7.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.14.5 FluimediX Recent Development

7.15 Fluxergy

7.15.1 Fluxergy Company Details

7.15.2 Fluxergy Business Overview

7.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction

7.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.15.5 Fluxergy Recent Development

7.16 Focus Diagnostics (DiaSorin Molecular)

7.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details

7.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview

7.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction

7.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development

7.17 Future Horizon Scientific

7.17.1 Future Horizon Scientific Company Details

7.17.2 Future Horizon Scientific Business Overview

7.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction

7.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.17.5 Future Horizon Scientific Recent Development

7.18 Genalyte

7.18.1 Genalyte Company Details

7.18.2 Genalyte Business Overview

7.18.3 Genalyte PCR-based Enteric Disease Testing Introduction

7.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.18.5 Genalyte Recent Development

7.19 GeneFluidics

7.19.1 GeneFluidics Company Details

7.19.2 GeneFluidics Business Overview

7.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction

7.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.19.5 GeneFluidics Recent Development

7.20 GenSpeed Biotech

7.20.1 GenSpeed Biotech Company Details

7.20.2 GenSpeed Biotech Business Overview

7.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction

7.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.20.5 GenSpeed Biotech Recent Development

7.21 Gulf Bio Analytical

7.21.1 Gulf Bio Analytical Company Details

7.21.2 Gulf Bio Analytical Business Overview

7.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction

7.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.21.5 Gulf Bio Analytical Recent Development

7.22 Hahn-Schickard

7.22.1 Hahn-Schickard Company Details

7.22.2 Hahn-Schickard Business Overview

7.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction

7.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.22.5 Hahn-Schickard Recent Development

7.23 Helvoet

7.23.1 Helvoet Company Details

7.23.2 Helvoet Business Overview

7.23.3 Helvoet PCR-based Enteric Disease Testing Introduction

7.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.23.5 Helvoet Recent Development

7.24 HemoCue

7.24.1 HemoCue Company Details

7.24.2 HemoCue Business Overview

7.24.3 HemoCue PCR-based Enteric Disease Testing Introduction

7.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.24.5 HemoCue Recent Development

7.25 Danaher

7.25.1 Danaher Company Details

7.25.2 Danaher Business Overview

7.25.3 Danaher PCR-based Enteric Disease Testing Introduction

7.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.25.5 Danaher Recent Development

7.26 IDEX Health&Science

7.26.1 IDEX Health&Science Company Details

7.26.2 IDEX Health&Science Business Overview

7.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction

7.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.26.5 IDEX Health&Science Recent Development

7.27 iLine Microsystems

7.27.1 iLine Microsystems Company Details

7.27.2 iLine Microsystems Business Overview

7.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction

7.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.27.5 iLine Microsystems Recent Development

7.28 Inflammatix

7.28.1 Inflammatix Company Details

7.28.2 Inflammatix Business Overview

7.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction

7.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022)

7.28.5 Inflammatix Recent Development

8 Research Findings and Conclusion

9 Appendix

9.1 Research Methodology

9.1.1 Methodology/Research Approach

9.1.2 Data Source

9.2 Author Details

9.3 Disclaimer

List of Tables

Table 1. PCR-based Enteric Disease Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)

Table 2. PCR-based Enteric Disease Testing Market Trends

Table 3. PCR-based Enteric Disease Testing Market Drivers

Table 4. PCR-based Enteric Disease Testing Market Challenges

Table 5. PCR-based Enteric Disease Testing Market Restraints

Table 6. Global PCR-based Enteric Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)

Table 7. United States PCR-based Enteric Disease Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)

Table 8. Global PCR-based Enteric Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)

Table 9. United States PCR-based Enteric Disease Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)

Table 10. Top PCR-based Enteric Disease Testing Companies in Global Market, Ranking by Revenue (2021)

Table 11. Global PCR-based Enteric Disease Testing Revenue by Player, (US$ Million), 2017-2022

Table 12. Global PCR-based Enteric Disease Testing Revenue Share by Player, 2017-2022

Table 13. Global PCR-based Enteric Disease Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global PCR-based Enteric Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2021)

Table 15. Top Players of PCR-based Enteric Disease Testing in Global Market, Headquarters and Area Served

Table 16. Companies Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million) Type

Table 17. Date of International Companies Enter into PCR-based Enteric Disease Testing Market

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Top PCR-based Enteric Disease Testing Players in United States Market, Ranking by Revenue (2021)

Table 20. United States PCR-based Enteric Disease Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022

Table 21. United States PCR-based Enteric Disease Testing Revenue Share by Players, 2020, 2021 & 2022

Table 22. Global PCR-based Enteric Disease Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028

Table 23. Global PCR-based Enteric Disease Testing Market Size by Region (2017-2022) & (US$ Million)

Table 24. Global PCR-based Enteric Disease Testing Market Size Forecast by Region (2023-2028) & (US$ Million)

Table 25. North America PCR-based Enteric Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)

Table 26. Asia Pacific PCR-based Enteric Disease Testing Sales in Value by Region (2017-2028) & (US$ Million)

Table 27. Europe PCR-based Enteric Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)

Table 28. Latin Americaa PCR-based Enteric Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)

Table 29. Middle East and Africa PCR-based Enteric Disease Testing Sales in Value by Country (2017-2028) & (US$ Million)

Table 30. Thermo Fisher Scientific Company Details

Table 31. Thermo Fisher Scientific Business Overview

Table 32. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product

Table 33. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 34. Thermo Fisher Scientific Recent Development

Table 35. Vela Diagnostics Company Details

Table 36. Vela Diagnostics Business Overview

Table 37. Vela Diagnostics PCR-based Enteric Disease Testing Product

Table 38. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 39. Vela Diagnostics Recent Development

Table 40. CorisBioconcept Company Details

Table 41. CorisBioconcept Business Overview

Table 42. CorisBioconcept PCR-based Enteric Disease Testing Product

Table 43. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 44. CorisBioconcept Recent Development

Table 45. Meridian Life Science Company Details

Table 46. Meridian Life Science Business Overview

Table 47. Meridian Life Science PCR-based Enteric Disease Testing Product

Table 48. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 49. Meridian Life Science Recent Development

Table 50. Bio-Rad Laboratories Company Details

Table 51. Bio-Rad Laboratories Business Overview

Table 52. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product

Table 53. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 54. Bio-Rad Laboratories Recent Development

Table 55. Abbott (ALERE) Company Details

Table 56. Abbott (ALERE) Business Overview

Table 57. Abbott (ALERE) PCR-based Enteric Disease Testing Product

Table 58. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 59. Abbott (ALERE) Recent Development

Table 60. bioMerieux SA Company Details

Table 61. bioMerieux SA Business Overview

Table 62. bioMerieux SA PCR-based Enteric Disease Testing Product

Table 63. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 64. bioMerieux SA Recent Development

Table 65. Trinity Biotech Company Details

Table 66. Trinity Biotech Business Overview

Table 67. Trinity Biotech PCR-based Enteric Disease Testing Product

Table 68. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 69. Trinity Biotech Recent Development

Table 70. DiaSorin Molecular Company Details

Table 71. DiaSorin Molecular Business Overview

Table 72. DiaSorin Molecular PCR-based Enteric Disease Testing Product

Table 73. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 74. DiaSorin Molecular Recent Development

Table 75. Etta Healthcare (Ovagene Oncology) Company Details

Table 76. Etta Healthcare (Ovagene Oncology) Business Overview

Table 77. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product

Table 78. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 79. Etta Healthcare (Ovagene Oncology) Recent Development

Table 80. ExcitePCR (PositiveID Corporation) Company Details

Table 81. ExcitePCR (PositiveID Corporation) Business Overview

Table 82. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product

Table 83. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 84. ExcitePCR (PositiveID Corporation) Recent Development

Table 85. Flow Alliance Company Details

Table 86. Flow Alliance Business Overview

Table 87. Flow Alliance PCR-based Enteric Disease Testing Product

Table 88. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 89. Flow Alliance Recent Development

Table 90. Fluid-Screen Company Details

Table 91. Fluid-Screen Business Overview

Table 92. Fluid-Screen PCR-based Enteric Disease Testing Product

Table 93. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 94. Fluid-Screen Recent Development

Table 95. FluimediX Company Details

Table 96. FluimediX Business Overview

Table 97. FluimediX PCR-based Enteric Disease Testing Product

Table 98. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 99. FluimediX Recent Development

Table 100. Fluxergy Company Details

Table 101. Fluxergy Business Overview

Table 102. Fluxergy PCR-based Enteric Disease Testing Product

Table 103. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 104. Fluxergy Recent Development

Table 105. Focus Diagnostics (DiaSorin Molecular) Company Details

Table 106. Focus Diagnostics (DiaSorin Molecular) Business Overview

Table 107. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product

Table 108. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 109. Focus Diagnostics (DiaSorin Molecular) Recent Development

Table 110. Future Horizon Scientific Company Details

Table 111. Future Horizon Scientific Business Overview

Table 112. Future Horizon Scientific PCR-based Enteric Disease Testing Product

Table 113. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 114. Future Horizon Scientific Recent Development

Table 115. Genalyte Company Details

Table 116. Genalyte Business Overview

Table 117. Genalyte PCR-based Enteric Disease Testing Product

Table 118. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 119. Genalyte Recent Development

Table 120. GeneFluidics Company Details

Table 121. GeneFluidics Business Overview

Table 122. GeneFluidics PCR-based Enteric Disease Testing Product

Table 123. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 124. GeneFluidics Recent Development

Table 125. GenSpeed Biotech Company Details

Table 126. GenSpeed Biotech Business Overview

Table 127. GenSpeed Biotech PCR-based Enteric Disease Testing Product

Table 128. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 129. GenSpeed Biotech Recent Development

Table 130. Gulf Bio Analytical Company Details

Table 131. Gulf Bio Analytical Business Overview

Table 132. Gulf Bio Analytical PCR-based Enteric Disease Testing Product

Table 133. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 134. Gulf Bio Analytical Recent Development

Table 135. Hahn-Schickard Company Details

Table 136. Hahn-Schickard Business Overview

Table 137. Hahn-Schickard PCR-based Enteric Disease Testing Product

Table 138. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 139. Hahn-Schickard Recent Development

Table 140. Helvoet Company Details

Table 141. Helvoet Business Overview

Table 142. Helvoet PCR-based Enteric Disease Testing Product

Table 143. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 144. Helvoet Recent Development

Table 145. HemoCue Company Details

Table 146. HemoCue Business Overview

Table 147. HemoCue PCR-based Enteric Disease Testing Product

Table 148. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 149. HemoCue Recent Development

Table 150. Danaher Company Details

Table 151. Danaher Business Overview

Table 152. Danaher PCR-based Enteric Disease Testing Product

Table 153. Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 154. Danaher Recent Development

Table 155. IDEX Health&Science Company Details

Table 156. IDEX Health&Science Business Overview

Table 157. IDEX Health&Science PCR-based Enteric Disease Testing Product

Table 158. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 159. IDEX Health&Science Recent Development

Table 160. iLine Microsystems Company Details

Table 161. iLine Microsystems Business Overview

Table 162. iLine Microsystems PCR-based Enteric Disease Testing Product

Table 163. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 164. iLine Microsystems Recent Development

Table 165. Inflammatix Company Details

Table 166. Inflammatix Business Overview

Table 167. Inflammatix PCR-based Enteric Disease Testing Product

Table 168. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)

Table 169. Inflammatix Recent Development

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. PCR-based Enteric Disease Testing Product Picture

Figure 2. Global PCR-based Enteric Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028

Figure 3. Global PCR-based Enteric Disease Testing Market Size 2017-2028 (US$ Million)

Figure 4. United States PCR-based Enteric Disease Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028

Figure 5. United States PCR-based Enteric Disease Testing Market Size 2017-2028 (US$ Million)

Figure 6. United States PCR-based Enteric Disease Testing Market Share in Global 2017-2028

Figure 7. PCR-based Enteric Disease Testing Report Years Considered

Figure 8. Product Picture of Analyzers/Instruments

Figure 9. Product Picture of Kits/Panels

Figure 10. Global PCR-based Enteric Disease Testing Market Share by Type in 2022 & 2028

Figure 11. Global PCR-based Enteric Disease Testing Market Size by Type (2017-2028) & (US$ Million)

Figure 12. Global PCR-based Enteric Disease Testing Market Share by Type (2017-2028)

Figure 13. United States PCR-based Enteric Disease Testing Market Share by Type in 2022 & 2028

Figure 14. United States PCR-based Enteric Disease Testing Market Size by Type (2017-2028) & (US$ Million)

Figure 15. United States PCR-based Enteric Disease Testing Market Share by Type (2017-2028)

Figure 16. Product Picture of Clostridium Difficile

Figure 17. Product Picture of Campylobacteriosis

Figure 18. Product Picture of Cholera

Figure 19. Product Picture of E. coli Infection

Figure 20. Product Picture of H. pylori Infection

Figure 21. Product Picture of Salmonellosis

Figure 22. Product Picture of Shigellosis

Figure 23. Product Picture of Rotavirus Infection

Figure 24. Product Picture of Norovirus Infection

Figure 25. Product Picture of Parasitic Enteric Disease

Figure 26. Global PCR-based Enteric Disease Testing Market Share by Application in 2022 & 2028

Figure 27. Global PCR-based Enteric Disease Testing Market Size by Application (2017-2028) & (US$ Million)

Figure 28. Global PCR-based Enteric Disease Testing Market Share by Application (2017-2028)

Figure 29. United States PCR-based Enteric Disease Testing Market Share by Application in 2022 & 2028

Figure 30. United States PCR-based Enteric Disease Testing Market Size by Application (2017-2028) & (US$ Million)

Figure 31. United States PCR-based Enteric Disease Testing Market Share by Application (2017-2028)

Figure 32. North America PCR-based Enteric Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)

Figure 33. U.S. PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 34. Canada PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 35. Europe PCR-based Enteric Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)

Figure 36. Germany PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 37. France PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 38. U.K. PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 39. Italy PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 40. Russia PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 41. Asia-Pacific PCR-based Enteric Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)

Figure 42. China PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 43. Japan PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 44. South Korea PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 45. India PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 46. Australia PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 47. Taiwan PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 48. Indonesia PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 49. Thailand PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 50. Malaysia PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 51. Philippines PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 52. Latin America PCR-based Enteric Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)

Figure 53. Mexico PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 54. Brazil PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 55. Argentina PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 56. Middle East & Africa PCR-based Enteric Disease Testing Market Size Growth Rate 2017-2028 (US$ Million)

Figure 57. Turkey PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 58. Saudi Arabia PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 59. UAE PCR-based Enteric Disease Testing Market Size Growth Rate (2017-2028) & (US$ Million)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 61. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 62. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 63. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 64. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 65. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 66. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 67. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 68. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 69. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 70. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 71. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 72. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 73. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 74. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 75. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 76. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 77. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 78. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 79. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 80. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 81. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 82. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 83. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 84. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 85. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 86. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 87. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed